Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects

Schizophrenia Research

Volumn 115, Issue 2-3, 2009, Pages 372-373

  Fulzele, Sadanand ^a   Pillai, Anilkumar ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; VASCULOTROPIN;

ALCOHOL CONSUMPTION; AUTOPSY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LETTER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

GENE EXPRESSION REGULATION; HUMANS; PREFRONTAL CORTEX; RNA, MESSENGER; SCHIZOPHRENIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 71649092911     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.06.005     Document Type: Letter

References (9)

1. Andreasen N.C., O'Leary D.S., Flaum M., Nopoulos P., Watkins G.L., Boles Ponto L.L., and Hichwa R.D. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet 349 (1997) 1730-1734
2. Greenberg D.A., and Jin K. From angiogenesis to neuropathology. Nature 438 (2005) 954-959
3. Hanson D.R., and Gottesman I.I. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med. Genet. 6 (2005) 7
4. Newton S.S., and Duman R.S. Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs 21 9 (2007) 715-725
5. Pillai A., and Mahadik S.P. Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus. Schizophr. Res. 87 (2006) 48-59
6. Senitz D., and Winkelmann E. Neuronal structure abnormality in the orbito-frontal cortex of schizophrenics. J. Hirnforsch. 32 (1991) 149-158
7. Villringer A., and Dirnagl U. Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging. Cerebrovasc. Brain Metab. Rev. 7 3 (1995) 240-276 Fall
8. Warner-Schmidt J.L., and Duman R.S. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4647-4652
9. Wiser A.K., Andreasen N.C., O'Leary D.S., Watkins G.L., Boles Ponto L.L., and Hichwa R.D. Dysfunctional cortico-cerebellar circuits cause 'cognitive dysmetria' in schizophrenia. Neuroreport 9 (1998) 1895-1899